$3.27 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 87 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 42.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MSFT | Sell | MICROSOFT CORP | $183,675,000 | -36.9% | 595,747 | -31.1% | 5.61% | -0.4% |
| UNP | Sell | UNION PAC CORP | $167,649,000 | -17.6% | 613,628 | -24.1% | 5.12% | +29.9% |
| AMZN | Sell | AMAZON COM INC | $147,095,000 | -59.2% | 45,122 | -58.2% | 4.49% | -35.6% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $122,901,000 | -46.4% | 240,997 | -47.2% | 3.75% | -15.5% |
| EL | Sell | LAUDER ESTEE COS INCcl a | $101,432,000 | -39.0% | 372,475 | -17.1% | 3.10% | -3.8% |
| CNC | New | CENTENE CORP DEL | $100,793,000 | – | 1,197,206 | +100.0% | 3.08% | – |
| OTIS | Sell | OTIS WORLDWIDE CORP | $99,841,000 | -53.8% | 1,297,480 | -47.8% | 3.05% | -27.2% |
| V | New | VISA INC | $97,133,000 | – | 437,990 | +100.0% | 2.97% | – |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $93,738,000 | +43.1% | 1,531,923 | +22.4% | 2.86% | +125.6% |
| IQV | Sell | IQVIA HLDGS INC | $89,411,000 | -43.4% | 386,710 | -30.9% | 2.73% | -10.7% |
| LVS | New | LAS VEGAS SANDS CORP | $88,440,000 | – | 2,275,282 | +100.0% | 2.70% | – |
| TPR | Sell | TAPESTRY INC | $86,192,000 | -53.3% | 2,320,100 | -49.0% | 2.63% | -26.3% |
| SPGI | New | S&P GLOBAL INC | $84,809,000 | – | 206,760 | +100.0% | 2.59% | – |
| SCHW | New | SCHWAB CHARLES CORP | $82,859,000 | – | 982,790 | +100.0% | 2.53% | – |
| HUM | New | HUMANA INC | $82,198,000 | – | 188,888 | +100.0% | 2.51% | – |
| RPRX | Buy | ROYALTY PHARMA PLC | $78,918,000 | +0.7% | 2,025,610 | +3.0% | 2.41% | +58.8% |
| GFL | Sell | GFL ENVIRONMENTAL INC | $74,337,000 | -57.6% | 2,284,496 | -50.6% | 2.27% | -33.0% |
| JNJ | New | JOHNSON & JOHNSON | $73,605,000 | – | 415,310 | +100.0% | 2.25% | – |
| DHR | Buy | DANAHER CORPORATION | $68,220,000 | -5.8% | 232,570 | +5.6% | 2.08% | +48.5% |
| MA | Sell | MASTERCARD INCORPORATEDcl a | $68,239,000 | -24.1% | 190,943 | -23.7% | 2.08% | +19.7% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $67,966,000 | -62.3% | 115,069 | -57.5% | 2.08% | -40.6% |
| KURA | Buy | KURA ONCOLOGY INC | $62,600,000 | +25.2% | 3,893,019 | +9.0% | 1.91% | +97.5% |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $61,807,000 | +47.1% | 2,613,412 | +10.0% | 1.89% | +131.9% |
| RH | Sell | RH | $59,295,000 | -55.7% | 181,835 | -27.2% | 1.81% | -30.2% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $59,275,000 | -64.1% | 383,138 | -69.2% | 1.81% | -43.4% |
| HLT | Sell | HILTON WORLDWIDE HLDGS INC | $55,037,000 | -41.1% | 362,703 | -39.5% | 1.68% | -7.1% |
| MAR | Sell | MARRIOTT INTL INC NEWcl a | $54,349,000 | -33.4% | 309,240 | -37.4% | 1.66% | +5.1% |
| XLE | New | SELECT SECTOR SPDR TRenergy | $52,963,000 | – | 692,868 | +100.0% | 1.62% | – |
| New | BATH & BODY WORKS INC | $49,647,000 | – | 1,038,630 | +100.0% | 1.52% | – | |
| MQ | Buy | MARQETA INC | $44,711,000 | +77.5% | 4,049,950 | +176.0% | 1.37% | +179.9% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $41,959,000 | -29.0% | 510,331 | +26.7% | 1.28% | +12.1% |
| DECK | Sell | DECKERS OUTDOOR CORP | $39,006,000 | -50.8% | 142,477 | -34.1% | 1.19% | -22.3% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $38,133,000 | -6.5% | 525,100 | +8.2% | 1.16% | +47.5% |
| EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $35,349,000 | +14.6% | 2,909,407 | +15.5% | 1.08% | +80.9% |
| AGIO | AGIOS PHARMACEUTICALS INC | $34,273,000 | -11.4% | 1,177,374 | 0.0% | 1.05% | +39.8% | |
| INSM | Buy | INSMED INC | $30,983,000 | +5.2% | 1,318,432 | +21.9% | 0.95% | +66.0% |
| STRO | Buy | SUTRO BIOPHARMA INC | $30,680,000 | -15.4% | 3,732,400 | +53.1% | 0.94% | +33.5% |
| MCK | New | MCKESSON CORP | $29,995,000 | – | 97,980 | +100.0% | 0.92% | – |
| WYNN | New | WYNN RESORTS LTD | $29,190,000 | – | 366,060 | +100.0% | 0.89% | – |
| Buy | MARINUS PHARMACEUTICALS INC | $25,862,000 | -17.5% | 2,766,000 | +4.8% | 0.79% | +30.1% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $25,740,000 | +11.4% | 1,746,300 | 0.0% | 0.79% | +75.8% | |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $24,025,000 | +60.5% | 3,014,408 | +12.8% | 0.73% | +153.1% |
| NTRA | Sell | NATERA INC | $23,784,000 | -60.0% | 584,660 | -8.1% | 0.73% | -36.8% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $23,464,000 | +15.3% | 1,434,200 | +15.0% | 0.72% | +82.0% |
| KZR | KEZAR LIFE SCIENCES INC | $23,433,000 | -0.6% | 1,409,956 | 0.0% | 0.72% | +57.0% | |
| CANO | Sell | CANO HEALTH INC | $23,295,000 | -73.5% | 3,668,478 | -62.8% | 0.71% | -58.2% |
| XOP | New | SPDR SER TRs&p oilgas exp | $22,197,000 | – | 164,970 | +100.0% | 0.68% | – |
| New | ARCELLX INC | $21,493,000 | – | 1,533,059 | +100.0% | 0.66% | – | |
| XENE | XENON PHARMACEUTICALS INC | $21,154,000 | -2.1% | 692,000 | 0.0% | 0.65% | +54.2% | |
| HRTX | Buy | HERON THERAPEUTICS INC | $16,411,000 | -27.7% | 2,869,048 | +15.4% | 0.50% | +14.1% |
| PHVS | PHARVARIS N V | $15,007,000 | +26.0% | 827,540 | 0.0% | 0.46% | +98.3% | |
| CMRX | CHIMERIX INC | $12,671,000 | -28.8% | 2,766,619 | 0.0% | 0.39% | +12.5% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $10,239,000 | -30.0% | 9,142,067 | 0.0% | 0.31% | +10.6% | |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $9,338,000 | -23.5% | 4,059,894 | +57.9% | 0.28% | +20.8% |
| SLDB | Buy | SOLID BIOSCIENCES INC | $8,670,000 | -21.2% | 7,224,860 | +14.9% | 0.26% | +24.4% |
| MOLN | MOLECULAR PARTNERS AGads | $8,220,000 | +7.1% | 400,000 | 0.0% | 0.25% | +68.5% | |
| OTIC | Buy | OTONOMY INC | $7,546,000 | +35.5% | 3,144,196 | +17.4% | 0.23% | +113.9% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $7,308,000 | – | 61,631 | +100.0% | 0.22% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $6,763,000 | – | 406,200 | +100.0% | 0.21% | – |
| AMAM | Buy | AMBRX BIOPHARMA INCsponsored ads | $6,146,000 | -35.7% | 1,491,832 | +41.0% | 0.19% | +1.6% |
| BOLT | BOLT BIOTHERAPEUTICS INC | $6,111,000 | -44.1% | 2,230,250 | 0.0% | 0.19% | -11.8% | |
| IFRX | INFLARX NV | $6,012,000 | -61.6% | 3,285,000 | 0.0% | 0.18% | -39.3% | |
| RACB | RESEARCH ALLIANCE CORP II | $4,885,000 | 0.0% | 500,000 | 0.0% | 0.15% | +56.8% | |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $4,268,000 | – | 344,755 | +100.0% | 0.13% | – |
| INZY | INOZYME PHARMA INC | $4,144,000 | -40.0% | 1,013,216 | 0.0% | 0.13% | -5.2% | |
| SIOX | SIO GENE THERAPIES INC | $3,962,000 | -48.1% | 5,914,000 | 0.0% | 0.12% | -18.2% | |
| TERN | TERNS PHARMACEUTICALS INC | $3,679,000 | -58.0% | 1,238,800 | 0.0% | 0.11% | -34.1% | |
| ROIVANT SCIENCES LTD | $3,367,000 | -51.0% | 681,528 | 0.0% | 0.10% | -22.6% | ||
| GMTX | GEMINI THERAPEUTICS INC | $3,297,000 | -52.2% | 2,372,267 | 0.0% | 0.10% | -24.6% | |
| OMEG | OMEGA ALPHA SPACcl a | $2,946,000 | +0.5% | 300,000 | 0.0% | 0.09% | +57.9% | |
| EBAC | EUROPEAN BIOTECH ACQUTN CORP | $2,922,000 | +0.5% | 300,000 | 0.0% | 0.09% | +58.9% | |
| ORIC | ORIC PHARMACEUTICALS INC | $2,353,000 | -63.7% | 440,696 | 0.0% | 0.07% | -42.4% | |
| OPY ACQUISITION CORP Iunit 09/22/2026 | $1,999,000 | -0.1% | 200,000 | 0.0% | 0.06% | +56.4% | ||
| BLSA | BCLS ACQUISITION CORP | $1,974,000 | +0.7% | 200,000 | 0.0% | 0.06% | +57.9% | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $1,970,000 | +0.3% | 200,000 | 0.0% | 0.06% | +57.9% | |
| BNTC | BENITEC BIOPHARMA INC | $1,796,000 | -10.9% | 769,000 | 0.0% | 0.06% | +41.0% | |
| IMMUNEERING CORP | $1,294,000 | -60.0% | 200,000 | 0.0% | 0.04% | -36.5% | ||
| CANOWS | Sell | CANO HEALTH INC*w exp 06/03/202 | $1,065,000 | -33.9% | 674,066 | -0.1% | 0.03% | +6.5% |
| ENTRADA THERAPEUTICS INC | $995,000 | -45.2% | 106,000 | 0.0% | 0.03% | -14.3% | ||
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $984,000 | +0.8% | 99,999 | 0.0% | 0.03% | +57.9% | |
| FLAC | FRAZIER LIFESCIENCES ACQU CO | $860,000 | +0.8% | 87,498 | 0.0% | 0.03% | +52.9% | |
| DBTX | DECIBEL THERAPEUTICS INC | $801,000 | -34.7% | 263,600 | 0.0% | 0.02% | 0.0% | |
| MGTX | MEIRAGTX HLDGS PLC | $479,000 | -41.7% | 34,600 | 0.0% | 0.02% | -6.2% | |
| EBACW | EUROPEAN BIOTECH ACQUTN CORP*w exp 03/06/202 | $20,000 | -66.7% | 100,000 | 0.0% | 0.00% | 0.0% | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $22,000 | -51.1% | 66,666 | 0.0% | 0.00% | 0.0% | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $6,000 | -68.4% | 33,333 | 0.0% | 0.00% | – | |
| FLACW | FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202 | $7,000 | -58.8% | 29,166 | 0.0% | 0.00% | – | |
| FSRXW | Exit | FINSERV ACQUISITION CORP II*w exp 02/17/202 | $0 | – | -273,149 | -100.0% | -0.00% | – |
| SRNE | Exit | SORRENTO THERAPEUTICS INC | $0 | – | -105,744 | -100.0% | -0.01% | – |
| Exit | NUVALENT INC | $0 | – | -200,000 | -100.0% | -0.07% | – | |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -265,116 | -100.0% | -0.08% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INCcall | $0 | – | -367,100 | -100.0% | -0.10% | – |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -851,291 | -100.0% | -0.11% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -410,000 | -100.0% | -0.20% | – | |
| Exit | GRAB HOLDINGS LIMITEDclass a ord | $0 | – | -2,000,000 | -100.0% | -0.28% | – | |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -1,218,792 | -100.0% | -0.38% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -245,800 | -100.0% | -0.44% | – |
| ETSY | Exit | ETSY INC | $0 | – | -122,158 | -100.0% | -0.52% | – |
| KBR | Exit | KBR INC | $0 | – | -685,500 | -100.0% | -0.63% | – |
| Exit | WARBY PARKER INC | $0 | – | -733,402 | -100.0% | -0.66% | – | |
| CPRT | Exit | COPART INC | $0 | – | -305,000 | -100.0% | -0.90% | – |
| Exit | RIVIAN AUTOMOTIVE INC | $0 | – | -507,830 | -100.0% | -1.02% | – | |
| TEL | Exit | TE CONNECTIVITY LTD | $0 | – | -382,623 | -100.0% | -1.20% | – |
| SQ | Exit | BLOCK INCcl a | $0 | – | -429,984 | -100.0% | -1.34% | – |
| ALIT | Exit | ALIGHT INC | $0 | – | -7,810,000 | -100.0% | -1.64% | – |
| OPEN | Exit | OPENDOOR TECHNOLOGIES INC | $0 | – | -6,168,996 | -100.0% | -1.74% | – |
| CVNA | Exit | CARVANA COcl a | $0 | – | -427,807 | -100.0% | -1.92% | – |
| MNST | Exit | MONSTER BEVERAGE CORP NEW | $0 | – | -1,143,700 | -100.0% | -2.13% | – |
| PWR | Exit | QUANTA SVCS INC | $0 | – | -1,163,015 | -100.0% | -2.58% | – |
| ADI | Exit | ANALOG DEVICES INC | $0 | – | -819,310 | -100.0% | -2.79% | – |
| ADBE | Exit | ADOBE SYSTEMS INCORPORATED | $0 | – | -392,207 | -100.0% | -4.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.